Lodo Therapeutics

Lodo Therapeutics Discovers and Develops Novel Treatments for "Undruggable" Targets by Applying Its Proprietary Platform to Mine the Vast Number of Undiscovered Molecules Encoded in Environmental Microbial DNA. These Drug-Like Molecules Span a Wide Range of Structural Diversity, and Their Biological Relevance Has Been Optimized by Billions of Years of Evolution. Lodo’s Proprietary Platform Leverages Breakthroughs in Next-Generation Sequencing, Artificial Intelligence/Machine Learning, and Synthetic Biology to Increase the Speed and Efficiency of Natural Product Drug Discovery by Several Orders of Magnitude. Following Successful Initial Collaborations with Two Global Partners, Lodo Is Advancing an Internal Pipeline Initially Focused on Oncology and Expanding Its Collaborative Activities Across a Range of Indications.